Tom DeMelfi, MS

Tom DeMelfi serves as the Vice President of Regulatory Affairs and Quality at Neuron23. Tom is a seasoned leader with over 32 years of combined experience in Global Regulatory Affairs, Business Development, and Research across small and large biotech and pharmaceutical companies, including Aadi Bioscience, Ionis Pharmaceuticals, Atara Biotherapeutics, Amgen, and SmithKline Beecham.

Tom has a robust background in global regulatory strategy leading successful projects from discovery through development and authorization across multiple therapeutic areas and modalities. He leverages his business development and research expertise as an Advisory Board Member at the Children’s Hospital Los Angeles where the board evaluates research projects seeking intramural funding.

Tom obtained his MS degree in Microbiology from Thomas Jefferson University and a BS degree in Biology from Bloomsburg University.